Healthcare-Specific Due Diligence: The Six Critical Domains

Introduction

Healthcare due diligence is fundamentally different from diligence in other sectors because healthcare companies operate within a regulatory, reimbursement, and clinical framework that creates risk categories with no equivalent elsewhere. A standard financial and legal diligence process that would be sufficient for a technology or industrial acquisition will miss the specific risks that most frequently destroy value in healthcare transactions. Healthcare bankers must understand each diligence domain to effectively advise clients on both buy-side risk assessment and sell-side preparation.

The six domains are not independent. Findings in one domain frequently surface issues in others: a fraud and abuse concern may reveal reimbursement irregularities, a quality-of-care deficiency may indicate operational staffing problems, and a technology gap may create HIPAA compliance exposure. Effective healthcare diligence integrates findings across all six domains to build a comprehensive risk picture.

Standard financial diligence (reviewing historical financials, analyzing trends, validating EBITDA) applies in healthcare but must be supplemented with healthcare-specific financial analysis.

Payer Mix Analysis

Payer mix is the single most important financial diligence item in healthcare services transactions. The analysis must go beyond simply categorizing revenue as commercial, Medicare, or Medicaid. Effective payer mix diligence includes:

Revenue Cycle Health

Revenue cycle metrics reveal how effectively the target converts clinical services into collected revenue. Key diligence metrics include:

Poor revenue cycle metrics can signal both a risk (revenue leakage that may continue post-acquisition) and an opportunity (a PE acquirer with centralized RCM capabilities can recover 5-15% of leaked revenue, as discussed in the PE value creation playbook).

Reimbursement Rate Analysis

Beyond payer mix, diligence must analyze the actual reimbursement rates the target receives relative to benchmarks. Is the target receiving rates above, at, or below market for its specialty and geography? Above-market rates may indicate a strong negotiating position (positive) or may not survive post-acquisition renegotiation if the acquirer triggers change-of-control provisions in payer contracts. Below-market rates may represent upside if the acquirer has greater payer negotiating leverage.

Healthcare regulatory compliance diligence verifies that the target holds all required licenses, certifications, and approvals and is operating within the boundaries of its regulatory authorizations.

Licensure and Accreditation

Every healthcare facility and provider must hold state licensure appropriate to the services it provides. Diligence must verify current licensure status, any pending or recent disciplinary actions, and the timeline for licensure renewal. For facilities that accept Medicare, accreditation by an approved accrediting organization (The Joint Commission, AAAHC, ACHC) is typically required and must be verified.

Deemed Status

The status a healthcare facility receives when it is accredited by a CMS-approved accrediting organization, meaning it is "deemed" to meet Medicare Conditions of Participation without requiring a separate CMS survey. Losing accreditation, and therefore deemed status, could terminate the facility's ability to participate in Medicare, which would be catastrophic for revenue. During diligence, verifying the accreditation status, most recent survey results, any outstanding corrective action plans, and the accreditation renewal timeline is essential.

Medicare and Medicaid Enrollment

Active enrollment in Medicare and Medicaid programs must be verified for every participating provider and facility. Enrollment gaps, pending revalidation, or a history of revoked enrollment are serious red flags. The diligence should also check the OIG List of Excluded Individuals/Entities (LEIE) to confirm that no providers or employees at the target are excluded from federal healthcare programs, as employing an excluded individual can result in civil monetary penalties and program exclusion for the entire entity.

Fraud and abuse diligence is uniquely critical in healthcare because the regulatory framework creates criminal and civil liability for billing practices, referral relationships, and compensation arrangements that would be unremarkable in other industries.

Fraud and abuse diligence for healthcare transactions must examine physician compensation arrangements (are they at fair market value?), referral patterns (do they correlate with financial relationships?), billing practices (is coding accurate and compliant?), and any history of government investigations, qui tam suits, or corporate integrity agreements. In FY2025, one of the largest settlements involved allegations that a healthcare network paid physician compensation far above fair market value and tied bonuses to referral volume, resulting in a $345 million settlement. This case illustrates the exact intersection of Stark, AKS, and FCA exposure that diligence must surface.

Quality-of-care diligence assesses clinical outcomes, patient safety, and the target's standing with regulators and accrediting bodies. While not traditionally a financial diligence item, quality issues directly impact financial performance through increased malpractice costs, CMS penalties (Hospital Value-Based Purchasing, Hospital Readmissions Reduction Program), payer contract termination, and reputational damage.

Key quality diligence items include clinical outcome metrics relative to benchmarks, malpractice claims history and open litigation, patient satisfaction scores (HCAHPS for hospitals, CG-CAHPS for physician practices), infection rates and adverse event reporting, and any CMS Conditions of Participation deficiencies.

Value-Based Payment Exposure Analysis

As CMS and commercial payers shift toward value-based reimbursement, diligence must quantify the target's exposure to performance-based payment adjustments. This analysis goes beyond current quality scores to assess the trajectory: is the target improving or declining on quality measures? What percentage of total revenue is subject to value-based adjustments (and therefore at risk if quality deteriorates)? For hospitals, the Hospital Value-Based Purchasing Program, Hospital Readmissions Reduction Program, and Hospital-Acquired Condition Reduction Program each impose separate penalties that can compound. A hospital simultaneously penalized across all three programs could lose 4-6% of Medicare payments, which for a hospital with $500 million in Medicare revenue translates to $20-30 million in annual penalties. For physician practices participating in the Merit-based Incentive Payment System (MIPS) or Advanced Alternative Payment Models, the quality score trajectory directly impacts future reimbursement rates. Diligence should model the financial impact of the target's current quality trajectory under each value-based program it participates in, including the revenue at risk under downside scenarios.

Electronic Health Records and Technology Infrastructure

The target's EHR system, practice management software, billing platform, and technology infrastructure affect both operational efficiency and integration complexity. Diligence should assess the current technology stack, licensing costs, contract terms (especially cloud-based EHR contracts with minimum terms), interoperability with the acquirer's systems, and the technology migration plan.

HIPAA Compliance

The Health Insurance Portability and Accountability Act requires healthcare entities to protect patient health information (PHI) through administrative, physical, and technical safeguards. HIPAA diligence includes reviewing the target's security risk assessment, breach notification history (any breaches involving 500+ individuals are publicly reported on the HHS breach portal), security policies and procedures, employee training documentation, and business associate agreements with vendors that access PHI.

AI Governance and Compliance: The Emerging Seventh Domain

The rapid adoption of artificial intelligence across healthcare, from clinical decision-support tools and ambient listening for documentation to administrative automation and predictive analytics, has created an entirely new dimension of technology diligence that did not exist three years ago. AI diligence is rapidly becoming as important as HIPAA diligence because the compliance risks are substantial and the regulatory landscape is evolving quickly.

Diligence of a target's AI footprint should assess several critical areas. First, what AI tools are deployed, and which interact with protected health information or influence clinical decisions? High-risk AI applications (clinical decision support, diagnostic algorithms, treatment recommendations) carry significantly greater compliance and liability exposure than low-risk applications (scheduling optimization, billing automation). Second, does the target have a formal AI governance framework, including policies for evaluating, approving, monitoring, and retiring AI tools? An estimated 85% of healthcare AI investment currently flows to startups, amplifying vendor risk significantly because many early-stage AI vendors lack the operational maturity, HIPAA controls, and validation history that established technology providers offer.

Operational diligence in healthcare focuses on the operational factors that determine the target's ability to deliver services and generate revenue going forward.

Staffing and credentialing. The single largest operational risk in healthcare services is labor. Diligence should analyze provider and staff turnover rates, open positions, use of temporary or locum tenens staff (expensive and potentially indicative of retention problems), provider credentialing status with hospitals and payers, and non-compete agreement enforceability.

Facility condition and lease terms. Physical facility condition affects both patient experience and capital expenditure requirements. Lease terms (duration, renewal options, co-tenancy clauses) affect occupancy cost predictability.

Referral source analysis. For businesses that depend on physician referrals (ambulatory surgery centers, imaging centers, home health agencies), diligence should analyze referral concentration. If 50%+ of referrals come from 2-3 physicians, losing one referral source could materially impair revenue. The referral analysis must also cross-reference with the fraud and abuse domain: are any referring physicians compensated by the target (through medical directorships, consulting agreements, or equipment leases)? If so, those compensation arrangements must be evaluated for Stark Law and Anti-Kickback Statute compliance. A referral pattern that correlates with a financial relationship is a red flag that triggers deeper investigation.

Capacity and volume trend analysis. Diligence should examine the target's capacity utilization and patient volume trends at the individual site level, not just in aggregate. A multi-site healthcare services platform may show stable consolidated volume while individual locations exhibit divergent trends: some growing and approaching capacity constraints, others declining. Understanding site-level volume trajectories is critical for assessing capital expenditure needs (new capacity) and operational rationalization opportunities (consolidating underperforming locations). For ASCs and imaging centers, case mix evolution matters as much as total volume: a shift from higher-acuity, higher-reimbursement procedures to lower-acuity cases can erode revenue per case even as total case volume appears stable.

The next article covers quality of earnings analysis in healthcare and why standard QoE methodologies fall short in the sector.